Repeated activation, inflammatory lesion exposure, aging, and senescence-like programs in oligodendrocyte precursor cells may impair remyelination in progressive MS. The ALS extension is weak, so the prioritized hypothesis should focus on MS remyelination with safer differentiation-promoting or senescence-modulating strategies rather than toxic broad senolytics.
No linked papers recorded for this hypothesis yet.
No curated PDB or AlphaFold mapping for PDGFRA; yet. Search RCSB →
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for PDGFRA; CSPG4; CDKN2A; CDKN1A; GATA3.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
No resource usage or linked notebooks recorded for this hypothesis yet.